Dr. Laura T. Pizzi
Professor in the Department of Pharmacy Practice
Applying the tools of economic evaluation to improve healthcare value.
"I pursued applied health economics because I wanted to help shape decisions regarding the costs and real-world effectiveness of medicines and other treatments. Healthcare resources are limited, so this research is critical to informing which treatments should be covered by plans and chosen by patients and healthcare providers."
Cost and cost effectiveness of pharmacological and non-pharmacological treatments with an outcomes-oriented approach to improving the efficiency of care.
- Cost effectiveness of treatments and support programs for diseases in older adults, including dementia, gout, depression, glaucoma, diabetes, pneumococcal disease and cataracts
- Cost of blood products with a focus on plasma, from donation through delivery to patient
- Economic models estimating cost effectiveness of screening and vaginal progesterone treatment for prevention of preterm birth
- Cost effectiveness of a health navigator intervention for children with asthma
- Methods of interest include decision analysis, transition state models, microcost analysis and quality of life measurement
Dr. Pizzi’s research helps determine value of specific treatments to patients and healthcare decision makers.
In today’s healthcare economy, the innovators of new treatments face tough questions about their value compared to established treatments. In addition, there is a critical need to deliver the treatments we already have more efficiently. Dr. Pizzi’s research addresses these issues by answering the following questions:
- Should a new treatment be preferred based on its cost-effectiveness?
- What is the most efficient way to deliver a treatment to patients considering the staff, time and supplies required?
- How does a treatment effect patient’s quality of life as an important consideration when measuring healthcare value?
- What kind of economic evidence will the adopters of the treatment need to make an informed decision, considering current market forces such as reimbursement and health care coverage changes?
With 20 years of research experience, Dr. Pizzi is the first faculty member at the Jefferson College of Pharmacy to focus on interpreting and applying the tools of economic evaluation to the challenges of today’s healthcare landscape. Her research entails collaboration with interprofessional teams to develop and execute strategies for cost analysis that meet the informational needs of patients, health plans and health systems.
Dr. Pizzi receives funding from the National Institutes of Health in collaboration with Johns Hopkins University and University of Connecticut; the Center for Disease Control in collaboration with Wills Eye Hospital; and pharmaceutical sponsors.
- Deputy Editor for American Health and Drug Benefits
- Editorial board of PharmacoEconomics and the Jefferson Health Policy Newsletter
- Faculty Council of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
- Co-editor of Economic Evaluation in U.S. Healthcare: Principles and Applications
- Faculty advisor for the Jefferson Student Chapter of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
- Media advisor for the American Pharmacists Association
- Leader of the special interest group on Vision Cost Research, Wills Vision Research Center at Jefferson
- Reviewer for the 2nd U.S. Panel on Cost Effectiveness in Health and Medicine recommendations